Bioprocess Containers Market by Type(2D and 3D Bags, Accessories), Application(Process development, Upstream and Downstream Process), End User(Pharma & Biopharma Companies, CMOs & CROs, Academic & Research Institute), & Region – Global Forecast to 2026

Bioprocess Containers Market by Type(2D and 3D Bags, Accessories), Application(Process development, Upstream and Downstream Process), End User(Pharma & Biopharma Companies, CMOs & CROs, Academic & Research Institute), & Region – Global Forecast to 2026

The global bioprocess containers (BPCs) market is projected to grow from USD 2.9 billion in 2021 to USD 9.6 billion by 2026, at a CAGR of 26.3% during the forecast period. Growth in the bioprocess containers market is mainly driven by factors such as the growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising biopharmaceutical R&D. Emerging countries and the patent expiry of biologics are expected to offer growth opportunities for players operating in the bioprocess containers market during the forecast period.

“By end user segment, the CROs & CMOssegmentaccounted for the fastest-growing segment of thebioprocess containers market”

On the basis of end user, the bioprocess containers market is segmented into pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes. The CROs & CMOs segment is expected to be the fastest-growing segmentduring the forecast period.Growth in the number of biotechnology companies, a growing number of research projects in the pharmaceutical industry, and an increasing preference for outsourcing research and manufacturing activities are the key factors driving the growth of this segment.

“By application, the upstream processes segment accounted for the largest share of thebioprocess containers market”

On the basis of application, the bioprocess containers market is segmented into upstream processes, downstream processes, and process development. In 2020, the upstream processes segment accounted for the largest share of the bioprocess containers market. Upstream processes make the highest use of bioprocess containers, especially during fermentation and culture media processing; due to this, this segment holds the largest market share.

“Asia Pacific: The fastest-growing region in the bioprocess containersmarket.”

The APAC market is expected to register the highest CAGR during the forecast period. Factors such as the growing biopharmaceuticals industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies and key players in the region, and the growing number of CROs & CMOs in several APAC countries are contributing to the growth of this market.

“North America: the largest share of the bioprocess containers market”

North America accounted for the largest share of the bioprocess containers market. The large share of North America can be attributed to the presence of an established biopharmaceuticals industry and major players in the region.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent– Supply Side- 67%, Demand Side-33%
By Designation— CXOsand Directors- 18%, Executives - 25%, Mangers - 57%
By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%

The bioprocess containers market is dominated by a few globally established players such as Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck Millipore (Germany), Parker-Hannifin Corporation (US), Lonza AG (Switzerland), Michelin Group (France), Antylia Scientific (US), ABEC, Inc. (US), Meissner Filtration Products, Inc. (US), Avantor, Inc. (US), Corning Incorporated (US), and Entegris, Inc. (US), FlexBiosys Inc. (US), Cellexus (UK), Keofitt A/S (Denmark), FUJIMORI KOGYO CO., LTD. (Japan), CESCO Bioengineering Co., Ltd. (Taiwan), Solida Biotech GmbH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmbH (Switzerland), Celltainer Biotech BV (Netherlands), Foxx Life Sciences (US), and Shanghai Lepure Biotechnology Co., Ltd. (China).

Research Coverage:

The report segments the bioprocess containers market based on region (Asia Pacific, Europe, North America, and Rest of the World), type (2D bioprocess containers, 3D bioprocess containers, and other containers and accessories), application(upstream processes, downstream processes, and process development), end user (pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the bioprocess containersmarket.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the bioprocess containersmarket and provides them information on key market drivers, restraints, challenges, and opportunities.